查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1847802

數位PCR和即時PCR市場按產品類型、技術、樣品類型、應用和最終用戶分類－2025-2032年全球預測

Digital PCR & Real-Time PCR Market by Product Type, Technology, Sample Type, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，數位 PCR 和即時PCR市場將成長至 306.4 億美元，複合年成長率為 9.24%。

主要市場統計數據
基準年 2024 151億美元
預計年份：2025年 164.2億美元
預測年份：2032年 306.4億美元
複合年成長率 (%) 9.24%

本文全面探討了數位PCR和即時PCR的創新如何重新定義實驗室診斷、研究工作流程和操作重點。

數位PCR和即時PCR的融合開啟了分子分析的新時代，靈敏度、精確度和通量成為實驗室性能和臨床應用的關鍵決定因素。即時PCR奠定了核酸定量檢測的基準，至今仍是高性能診斷流程和符合監管要求的檢測的必備工具。同時，數位PCR作為一種互補技術脫穎而出，能夠對低豐度標靶進行絕對定量和卓越的性能，從而應用於從微小殘留病灶監測到精確拷貝數變異分析等諸多領域。這些平台共同重塑了診斷、環境監測、食品安全檢測和前沿研究應用中的數據可靠性。

在相關人員評估技術採納方案時，許多實際因素會影響採購和實施選擇。儀器佔地面積、樣本到結果的檢測時間、檢測方法遷移的便捷性、與實驗室資訊系統的整合以及試劑和耗材的可用性都至關重要。此外，不斷變化的監管要求和對可靠驗證數據的需求也推動了對標準化工作流程和認證試劑的需求。遷移決策正從戰術性轉向戰略層面，實驗室需要在營運效率與高解析度定量分析所帶來的臨床或科學研究價值之間取得平衡。

對塑造分子診斷生態系統的關鍵轉型轉變進行深入分析，包括技術應用、工作流程整合和價值鏈預期。

分子診斷領域正經歷著一場變革性的轉變，其驅動力包括技術成熟、工作流程整合以及終端使用者期望的改變。隨著供應商不斷改進通量、自動化和數據分析能力，數位PCR平台正從小眾應用走向更廣泛的普及，降低了實驗室常規部署的門檻。同時，即時PCR系統也不斷發展，其熱循環速度更快、具備多重PCR功能，並且擁有更完善的軟體生態系統，從而簡化了檢測方法的開發和法規遵從流程。這種雙軌發展趨勢正在推動混合實驗室策略的出現，即團隊利用即時PCR進行高性能篩檢，而利用數位PCR進行確證或高靈敏度檢測。

另一個重大轉變是對整合解決方案的需求，這些解決方案需要整合儀器、檢驗的試劑、軟體分析和服務協議。客戶現在期望供應商提供端到端的價值，包括簡化的偵測轉移、遠端故障排除和生命週期管理。同時，對分散式檢測和更貼近患者的診斷的日益重視，推動了儀器的微型化、加強和簡化使用者介面。隨著實驗室網路的擴展以及檢測結果對臨床決策的影響，資料完整性和網路安全也變得日益重要，從而推動了對可互通資料系統和符合審核要求的軟體功能的需求。

對美國關稅調整及其對供應鏈的影響（截至2025年）所產生的累積營運和策略影響進行嚴格評估

美國將於2025年實施新的關稅政策，這給分子診斷供應鏈中的製造商、經銷商和實驗室採購商帶來了複雜的營運壓力。更高的進口關稅和更嚴格的海關監管增加了國際採購的儀器、試劑和特殊耗材的到岸成本，迫使採購團隊重新評估供應商關係和庫存策略。為此，一些供應商加快了在地化生產，並擴大了關鍵試劑的國內採購，以維持價格競爭力並保護自身營運免受關稅波動的影響。

除了成本壓力外，關稅也促使企業採取策略性庫存緩衝和長期供應協議，以平穩採購週期並保障臨床和研究的連續性。經銷商和終端用戶正在協商多年定價框架和寄售模式，以穩定供應鏈。這些調整會對營運產生直接影響，包括增加庫存所需的營運成本以及改變採購前置作業時間。中期來看，關稅環境可能會促使生產佈局重新調整，並使供應鏈韌性成為策略規劃的關鍵要素。

詳細的細分分析揭示了產品類型、技術形式、樣品矩陣、應用領域和最終用戶畫像如何驅動商業性技術優先事項。

細分市場洞察揭示了不同產品類型、技術、樣本類型、應用和終端用戶之間的細微需求促進因素，從而影響研發重點和商業化策略。按產品類型分類，儀器因其自動化和高通量而持續受到青睞，而試劑和耗材（例如酶、預混液和探針/引物）則是推動長期盈利的經常性收入的支柱。按技術分類，市場動態由數位PCR和即時PCR的並存構成，其中基於晶片和液滴的數位PCR在靈敏度和樣本試樣處理通量方面展開競爭，而定量即時PCR和逆轉錄即時PCR則滿足了基因表現和診斷檢測的廣泛需求。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在臨床診斷中採用多重數位PCR工作流程進行早期癌症突變檢測
  • 將基於 CRISPR 的即時PCR檢測方法整合到快速照護現場傳染病檢查中
  • 開發高通量微流體數位PCR平台以加速單細胞分析
  • 利用機器學習演算法提高即時PCR數據解讀的診斷準確性
  • 擴大數位PCR檢測範圍，此檢測可直接從檢體中進行檢測，並減少臨床實驗室的檢體處理時間。
  • 現場環境監測對可攜式即時PCR儀的需求日益成長
  • 用於數位PCR的可客製化檢測試劑套件能夠對研究中的罕見基因變異進行精確定量。
  • 推出靈敏度更高的數位液滴PCR技術，用於非侵入性產前檢測。
  • 多重即時PCR檢測板的出現，使得醫院能夠同時檢測多種呼吸道病原體。
  • 儀器製造商和試劑供應商攜手合作，最佳化數位化PCR工作流程

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按產品類型分類的數位PCR和即時PCR市場

  • 裝置
  • 試劑和耗材
    • 酵素
    • 母帶混音
    • 探針和引子
  • 服務
  • 軟體

9. 按技術分類的數位PCR和即時PCR市場

  • 數位PCR
    • 基於晶片的數位PCR
    • 液滴式數位PCR
  • 即時PCR
    • 定量即時PCR（qPCR）
    • 逆轉錄即時PCR（RT-qPCR）

第10章 依樣本類型分類的數位PCR和即時PCR市場

  • 血液樣本
    • 電漿
    • 血清
  • 環境樣品
    • 土壤樣本
    • 水樣
  • 食品樣品
  • 組織樣本

第11章 按應用分類的數位PCR和即時PCR市場

  • 臨床應用
    • 傳染病檢查
    • 腫瘤檢測
    • 移植診斷
  • 環境應用
  • 食品安全
    • 過敏原檢測
    • 病原體檢測
  • 法醫學應用
  • 研究用途
    • 基因表現
    • 單細胞分析
    • 幹細胞研究

第12章 依最終用戶分類的數位PCR和即時PCR市場

  • 學術研究機構
  • 臨床診斷實驗室
  • 法醫學實驗室
  • 製藥和生物技術公司

第13章：按地區分類的數位PCR和即時PCR市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的數位PCR和即時PCR市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國數位PCR與即時PCR市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Analytik Jena GmbH+Co. KG
    • Azure Biosystems Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Biocompare
    • BIOMERIEUX SA
    • Bioneer Corporation
    • Danaher Corporation
    • ELITech Group by Bruker Corp
    • Enzo Life Sciences, Inc.
    • Eppendorf SE
    • Etcon Analytical and Environmental Systems & Services Ltd.
    • Explorea sro
    • F. Hoffmann-La Roche Ltd.
    • Hangzhou Longgene Scientific Instruments Co., Ltd.
    • Heal Force Bio-Meditech Holdings Limited
    • LABGENE Scientific SA
    • Merck KGaA
    • Promega Corporation
    • QIAGEN NV
    • Quidel Corporation
    • R-Biopharm AG
    • RainSure Scientific
    • SD Biosensor, Inc.
    • Solis BioDyne OU
    • STANDARD BIOTOOLS INC.
    • Takara Bio USA, Inc.
    • Thermo Fisher Scientific Inc.
    • Zymo Research Corp.
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market is projected to grow by USD 30.64 billion at a CAGR of 9.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 15.10 billion
Estimated Year [2025] USD 16.42 billion
Forecast Year [2032] USD 30.64 billion
CAGR (%) 9.24%

Comprehensive introduction to how digital PCR and real-time PCR innovations are redefining laboratory diagnostics, research workflows, and operational priorities

The convergence of digital PCR and real-time PCR has accelerated a new era in molecular analysis, where sensitivity, precision, and throughput are key determinants of laboratory performance and clinical impact. Real-time PCR established a baseline for quantitative nucleic acid detection and remains indispensable for high-throughput diagnostic workflows and regulatory-compliant testing. Meanwhile, digital PCR has emerged as a complementary technology that delivers absolute quantification and superior performance for low-abundance targets, enabling applications from minimal residual disease monitoring to precise copy number variation analysis. Together, these platforms are redefining data reliability in diagnostics, environmental surveillance, food safety testing, and advanced research applications.

As stakeholders evaluate technology adoption, several practical considerations shape procurement and implementation choices. Instrument footprint, sample-to-answer turnaround time, ease of assay migration, integration with laboratory information systems, and the availability of reagents and consumables are all critical. In addition, evolving regulatory expectations and the need for robust validation data drive demand for standardized workflows and certified reagents. Transition decisions are increasingly strategic rather than tactical, with laboratories balancing operational efficiency against the clinical or scientific value delivered by higher-resolution quantification.

Detailed analysis of major transformative shifts in technology adoption, workflow integration, and value chain expectations reshaping the molecular diagnostics ecosystem

The molecular diagnostics landscape is undergoing transformative shifts driven by technological maturation, workflow consolidation, and shifting end-user expectations. Digital PCR platforms have moved beyond niche use to broader adoption as vendors refine throughput, automation, and data analysis capabilities, reducing the friction for routine laboratory deployment. Concurrently, real-time PCR systems continue to evolve with faster thermocycling, multiplexing capacity, and enhanced software ecosystems that simplify assay development and regulatory compliance. This dual-track evolution is encouraging hybrid laboratory strategies, where teams deploy real-time PCR for high-throughput screening and digital PCR for confirmatory or high-sensitivity use cases.

Another major shift is the demand for integrated solutions that combine instrumentation, validated reagents, software analytics, and service agreements. Customers now expect vendors to deliver end-to-end value, including simplified assay transfer, remote troubleshooting, and lifecycle management. In parallel, greater emphasis on decentralized testing and near-patient diagnostics is prompting compact, robust instrument formats and simplified user interfaces. Data integrity and cybersecurity are also rising priorities as laboratory networks expand and results drive clinical decision-making, increasing the need for interoperable data systems and audit-ready software functionality.

Rigorous assessment of the cumulative operational and strategic effects resulting from United States tariff adjustments implemented during 2025 and their implications for supply chains

The introduction of new tariff measures by the United States in 2025 has created a complex set of operational pressures for manufacturers, distributors, and laboratory purchasers within the molecular diagnostics supply chain. Increased import duties and broader customs scrutiny have elevated landed costs for instruments, reagents, and specialty consumables sourced internationally, driving procurement teams to reassess supplier relationships and inventory strategies. In response, some vendors have accelerated localization of manufacturing and broadened domestic sourcing for critical reagents to maintain competitive pricing and shield operations from further tariff volatility.

In addition to cost pressures, tariffs have incentivized strategic inventory buffering and longer-term supply agreements to smooth procurement cycles and protect clinical and research continuity. Distributors and end-users are negotiating multi-year pricing frameworks and consignment models to stabilize supply lines. These adjustments have immediate operational implications, including increased working capital requirements for inventory and altered procurement lead times. Over the medium term, the tariff environment is likely to catalyze a redistribution of manufacturing footprints and a renewed focus on supply chain resilience as a key dimension of strategic planning.

In-depth segmentation analysis illuminating how product type, technological format, sample matrix, application area, and end-user profile drive commercial and technical priorities

Segmentation insights reveal nuanced demand drivers across product types, technologies, sample types, applications, and end users that are shaping development priorities and commercialization strategies. Based on product type, instruments continue to command attention for automation and throughput improvements while reagents and consumables such as enzymes, master mixes, and probes and primers remain the recurring revenue backbone that determines long-term profitability; services and software are increasingly offered as value-added components to lock in customer relationships. Based on technology, the market dynamic is defined by the coexistence of digital PCR and real-time PCR, where chip-based and droplet digital PCR formats compete on sensitivity and sample throughput, and where quantitative real-time PCR and reverse transcription real-time PCR sustain broad demand for gene expression and diagnostic assays.

Based on sample type, blood samples including plasma and serum are central to clinical diagnostics and biomarker applications, while environmental samples such as soil and water demand ruggedized workflows for field and surveillance testing; food samples and tissue samples present distinct extraction and assay validation needs that influence reagent formulations and QC processes. Based on application, clinical applications encompass infectious disease testing, oncology testing, and transplant diagnostics, while environmental applications, food safety with allergen and pathogen testing, forensic applications, and research applications such as gene expression, single cell analysis, and stem cell research each have bespoke performance and validation requirements. Based on end user, academic and research institutes emphasize innovation and method development, clinical diagnostics laboratories prioritize throughput and regulatory compliance, forensic labs require chain-of-custody assurance and validation rigor, and pharmaceutical and biotechnology companies seek scalable platforms for both discovery and regulated workflows. Together these segmentation lenses inform product design, pricing strategies, go-to-market planning, and service offerings across the industry.

Comprehensive regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence adoption, regulation, and commercial approaches

Regional dynamics are shaping technology adoption, regulatory pathways, and commercial strategies in distinctive ways across core geographies. In the Americas, demand is heavily influenced by clinical laboratory consolidation, payer dynamics, and a strong emphasis on precision diagnostics, driving investment in platforms that deliver clinical-grade data with scalable throughput. North American markets also prioritize rapid assay validation and integration with electronic health record systems, which favors vendors that provide robust documentation and interoperability. Latin American territories exhibit growing public health surveillance needs and are increasingly focused on cost-effective reagent supply and training programs to expand molecular testing access.

In Europe, Middle East & Africa, diverse regulatory frameworks and variable laboratory infrastructures create a mosaic of adoption patterns that require localized regulatory support and flexible service models. Western Europe tends to adopt advanced technologies rapidly due to strong research ecosystems and established clinical networks, whereas parts of the Middle East and Africa emphasize capacity building and partnerships for sustainable testing programs. In the Asia-Pacific region, high-volume testing needs, strong manufacturing capabilities, and rapid commercialization cycles encourage intense competition and fast iteration on instrument features. Several markets in Asia-Pacific are simultaneously scaling decentralized testing and investing in centralized reference laboratories, which opens pathways for both compact point-of-care formats and high-throughput real-time PCR systems.

Strategic company behaviors and competitive positioning insights revealing how technology roadmaps, partnerships, and service models are shaping vendor differentiation

Company strategies across the molecular diagnostics landscape reflect a balance between technological differentiation, commercial reach, and lifecycle support. Leading instrument manufacturers are prioritizing systems that enable seamless assay transfer between real-time and digital platforms, while expanding installed-base service offerings to increase recurring revenue. Reagent suppliers are emphasizing assay standardization and compatibility with multiple instrument ecosystems to lower barriers for customers and to foster brand loyalty. Software and analytics providers are maturing their platforms to provide cloud-enabled data management, advanced curve-fitting algorithms, and compliance-ready audit trails that address both laboratory efficiency and regulatory reporting needs.

Strategic partnerships, targeted acquisitions, and collaborative development agreements are also prominent as companies seek to offer bundled solutions and accelerate time to market for validated assays. Companies that offer comprehensive training programs, strong technical support, and accessible validation resources gain competitive advantage in health systems and research institutions that require rapid adoption with minimal disruption. Finally, firms that invest in regional manufacturing and robust supply chain networks are better positioned to mitigate tariff exposure and to respond to local procurement preferences, creating differentiated value propositions in price-sensitive markets.

Actionable recommendations for industry leaders to enhance resilience, accelerate adoption, and optimize commercial models through product, supply chain, and service innovation

Industry leaders can take pragmatic, high-impact actions to strengthen resilience, accelerate adoption, and capture growth opportunities across diagnostic and research markets. First, prioritize modular product architectures and validated reagent ecosystems that enable customers to scale from proof-of-concept to routine testing without major workflow disruption. This approach reduces friction during procurement and supports longer customer lifecycles. Second, invest in regional manufacturing and diversified supplier networks to mitigate tariff exposure and to ensure continuity of critical reagent and consumable supply, thereby improving price predictability and customer trust.

Third, develop comprehensive service and support packages that include remote diagnostics, training, and co-validation programs to lower the operational burden on customers. Fourth, expand software capabilities that ensure data integrity, interoperability with laboratory information systems, and streamlined regulatory documentation to meet the needs of clinical laboratories. Finally, pursue targeted partnerships with clinical institutions, public health agencies, and research centers to co-develop high-value assays and to demonstrate real-world clinical utility, thereby accelerating uptake and building robust evidence for reimbursement and institutional adoption.

Transparent research methodology detailing interview-driven insights, literature synthesis, and validation steps used to produce actionable intelligence for decision-makers

The research methodology underpinning this analysis combines evidence synthesis, expert validation, and cross-functional triangulation to ensure credibility and relevance. Primary inputs included structured interviews with laboratory leaders, procurement officers, and R&D directors who provided firsthand perspectives on technology selection criteria, workflow constraints, and vendor performance. These qualitative insights were complemented by a systematic review of technical literature, regulatory guidance, product specifications, and recent peer-reviewed studies that document analytical performance characteristics and application outcomes for both digital PCR and real-time PCR platforms.

To ensure robustness, findings were cross-checked with vendor technical documentation and publicly available clinical validation studies. Supply chain and tariff impact assessments were informed by trade policy announcements, import/export trends, and stakeholder interviews with procurement specialists and distribution partners. Throughout the process, key assumptions and illustrative scenarios were validated with subject matter experts to reflect practical implementation realities and to identify critical uncertainties that warrant close monitoring by decision-makers.

Concluding synthesis emphasizing the complementary roles of digital PCR and real-time PCR and the strategic priorities required for sustainable adoption and impact

In summary, the interplay between digital PCR and real-time PCR technologies is creating a versatile toolkit for diagnostics, environmental surveillance, food safety, forensic work, and cutting-edge research. Laboratories are increasingly adopting hybrid strategies that leverage the throughput and regulatory maturity of real-time PCR alongside the sensitivity and absolute quantitation capabilities of digital PCR. At the same time, the 2025 tariff environment has underscored the importance of supply chain diversification, regional manufacturing, and integrated service offerings to protect margins and ensure uninterrupted testing capacity.

Looking ahead, success will hinge on the ability of vendors and laboratory leaders to align technical performance with operational realities, to invest in interoperable software and rigorous validation packages, and to forge collaborative models that demonstrate clinical or scientific value. By focusing on modular product design, resilient procurement strategies, and evidence-based assay development, organizations can capture the benefits of both technologies while navigating policy and market complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of multiplex digital PCR workflows for early cancer mutation detection in clinical diagnostics
  • 5.2. Integration of CRISPR-based real-time PCR assays for rapid point-of-care infectious disease testing
  • 5.3. Development of high-throughput microfluidic digital PCR platforms to accelerate single-cell analysis
  • 5.4. Use of machine learning algorithms in real-time PCR data interpretation to improve diagnostic accuracy
  • 5.5. Expansion of direct-from-sample digital PCR tests reducing sample processing time in clinical labs
  • 5.6. Growing demand for portable real-time PCR instruments for on-site environmental monitoring applications
  • 5.7. Customizable assay kits for digital PCR enabling precise quantification of rare genetic variants in research
  • 5.8. Implementation of digital droplet PCR for non-invasive prenatal testing with enhanced sensitivity
  • 5.9. Emergence of multiplex real-time PCR panels for simultaneous detection of respiratory pathogens in hospitals
  • 5.10. Collaboration between instrument manufacturers and reagent suppliers to optimize digital PCR workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Digital PCR & Real-Time PCR Market, by Product Type

  • 8.1. Instruments
  • 8.2. Reagents & Consumables
    • 8.2.1. Enzymes
    • 8.2.2. Master Mixes
    • 8.2.3. Probes & Primers
  • 8.3. Services
  • 8.4. Software

9. Digital PCR & Real-Time PCR Market, by Technology

  • 9.1. Digital PCR
    • 9.1.1. Chip-Based Digital PCR
    • 9.1.2. Droplet Digital PCR
  • 9.2. Real-Time PCR
    • 9.2.1. Quantitative Real-Time PCR (qPCR)
    • 9.2.2. Reverse Transcription Real-Time PCR (RT-qPCR)

10. Digital PCR & Real-Time PCR Market, by Sample Type

  • 10.1. Blood Samples
    • 10.1.1. Plasma
    • 10.1.2. Serum
  • 10.2. Environmental Samples
    • 10.2.1. Soil Samples
    • 10.2.2. Water Samples
  • 10.3. Food Samples
  • 10.4. Tissue Samples

11. Digital PCR & Real-Time PCR Market, by Application

  • 11.1. Clinical Applications
    • 11.1.1. Infectious Disease Testing
    • 11.1.2. Oncology Testing
    • 11.1.3. Transplant Diagnostics
  • 11.2. Environmental Applications
  • 11.3. Food Safety
    • 11.3.1. Allergen Testing
    • 11.3.2. Pathogen Testing
  • 11.4. Forensic Application
  • 11.5. Research Applications
    • 11.5.1. Gene Expression
    • 11.5.2. Single Cell Analysis
    • 11.5.3. Stem Cell Research

12. Digital PCR & Real-Time PCR Market, by End-User

  • 12.1. Academic & Research Institutes
  • 12.2. Clinical Diagnostics Laboratories
  • 12.3. Forensic Labs
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Digital PCR & Real-Time PCR Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Digital PCR & Real-Time PCR Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Digital PCR & Real-Time PCR Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories, Inc.
    • 16.3.2. Agilent Technologies, Inc.
    • 16.3.3. Analytik Jena GmbH+Co. KG
    • 16.3.4. Azure Biosystems Inc.
    • 16.3.5. Becton, Dickinson and Company
    • 16.3.6. Bio-Rad Laboratories, Inc.
    • 16.3.7. Biocompare
    • 16.3.8. BIOMERIEUX S.A.
    • 16.3.9. Bioneer Corporation
    • 16.3.10. Danaher Corporation
    • 16.3.11. ELITech Group by Bruker Corp
    • 16.3.12. Enzo Life Sciences, Inc.
    • 16.3.13. Eppendorf SE
    • 16.3.14. Etcon Analytical and Environmental Systems & Services Ltd.
    • 16.3.15. Explorea s.r.o
    • 16.3.16. F. Hoffmann-La Roche Ltd.
    • 16.3.17. Hangzhou Longgene Scientific Instruments Co., Ltd.
    • 16.3.18. Heal Force Bio-Meditech Holdings Limited
    • 16.3.19. LABGENE Scientific SA
    • 16.3.20. Merck KGaA
    • 16.3.21. Promega Corporation
    • 16.3.22. QIAGEN N.V.
    • 16.3.23. Quidel Corporation
    • 16.3.24. R-Biopharm AG
    • 16.3.25. RainSure Scientific
    • 16.3.26. SD Biosensor, Inc.
    • 16.3.27. Solis BioDyne OU
    • 16.3.28. STANDARD BIOTOOLS INC.
    • 16.3.29. Takara Bio USA, Inc.
    • 16.3.30. Thermo Fisher Scientific Inc.
    • 16.3.31. Zymo Research Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIGITAL PCR & REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA DIGIT